
Why Big Pharma Wants Chinese Drugs
Foreign corporations are aggressively licensing Chinese biotech to bring novel, "first-in-class" drugs to global markets. This massive pipeline shift demonstrates that Chinese pharmaceutical talent is now producing assets that frequently match or outperform Western treatments in both efficacy and safety. Alice Han and James Kynge are joined by Ruby Wang on China Decode.
The Prof G Pod – Scott Galloway
NYU Professor, best-selling author, business leader and serial entrepreneur Scott Galloway cuts through the biggest stories in tech, business, and investing with unfiltered insights, bold predictions and thoughtful advice. Podcasts include Markets with co...